News
-
Novartis To Start Construction Of New Biotechnology Facility In Singapore With An Investment Of Over USD 500 Million
10/31/2012
Novartis announced recently the construction of a new state-of-the-art biotechnology production site in Singapore with an investment valued at over USD 500 million. The new facility will focus on drug substance manufacturing based on cell culture technology.
-
ChromaDex® Announces The Award Of Two Method Validation Study Contracts From The Office Of Dietary Supplements, National Institutes Of Health
10/29/2012
ChromaDex® Corporation (CDXC), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure®, announced today the award of two method validation study contracts from the Office of Dietary Supplements (ODS), National Institutes of Health (NIH).
-
Pharmalink AB Receives Patent For Nefecon® Principle
10/26/2012
Pharmalink AB announced today that it has been granted Japanese Patent No 4326696, "Methods and means for treating glomerulonephritis" for its product Nefecon(R) which is being developed to treat IgA nephropathy, a glomerulonephritis leading to end-stage renal disease (ESRD).
-
Aptuit Offers Comprehensive Bundle Of Antibacterial Studies From A Single Site
10/17/2012
Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced the availability of bundled, comprehensive and integrated services in the antibacterial area from a single site, The Aptuit Center for Drug Discovery & Development in Verona, Italy.